Ubs Asset Management Americas Inc Ultragenyx Pharmaceutical Inc. Transaction History
Ubs Asset Management Americas Inc
- $381 Billion
- Q3 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 177,756 shares of RARE stock, worth $7.95 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
177,756
Previous 176,809
0.54%
Holding current value
$7.95 Million
Previous $7.27 Million
35.89%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding RARE
# of Institutions
325Shares Held
85.7MCall Options Held
520KPut Options Held
406K-
Vanguard Group Inc Valley Forge, PA9.95MShares$445 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$251 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA5.12MShares$229 Million0.91% of portfolio
-
Wellington Management Group LLP Boston, MA4.17MShares$186 Million0.04% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.07MShares$137 Million0.02% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $3.13B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...